Acute Graft Versus Host Disease clinical trials

Explore recruiting acute graft versus host disease clinical trials.

Recruiting acute graft versus host disease studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Acute Graft Versus Host Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

ALL SCTped 2012 FORUM - Allogeneic Stem Cell Transplantation in Children and Adolescents with Acute Lymphoblastic Leukaemia

Italy, Norway, Slovakia, Austria, Belgium, Germany +6 more

Phase II and Phase III (Integrated) EU CTIS Study details

Venetoclax as treatment of acute graft-versus-host disease in patients after allogeneic hematopoietic stem cell transplantation in a Phase-II dose escalation pilot study.

Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase 2 Open Label Prospective Dose-Ranging Clinical Trial with Escalation and Expansion Cohorts to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Dosing, and Efficacy of RLS-0071 for the Treatment of Hospitalized Patients with Steroid -Refractory Acute Graft-versus-Host Disease

Germany, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Multicenter Study of Itolizumab in Combination with Corticosteroids for the Initial Treatment of Acute Graft Versus Host Disease

Spain, Portugal, France, Germany, Belgium, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2/3, Multicenter, randOmized, Double-blind, placebo-controlled, stUdy to evaLuate the safety and efficacy of Alpha-1 AntiTrypsin for the prEvention of graft versus-host disease in patients receiving hematopoietic cell transplant (MODULAATE Study)

Spain, Italy, Germany

Phase II and Phase III (Integrated) EU CTIS Study details

A Randomised, Open label, Multicentre, Phase 3 Trial of First line Treatment with Mesenchymal Stromal Cells MC0518 Versus Best Available Therapy in Adult and Adolescent Subjects with Steroid refractory Acute Graft versus host Disease After Allogeneic Haematopoietic Stem Cell Transplantation (IDUNN Trial)

Poland, Spain, France, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Acute Graft Versus Host Disease trials by city

Acute Graft Versus Host Disease in Toronto Acute Graft Versus Host Disease in Vancouver Acute Graft Versus Host Disease in Montreal Acute Graft Versus Host Disease in Calgary Acute Graft Versus Host Disease in Edmonton Acute Graft Versus Host Disease in Ottawa Acute Graft Versus Host Disease in Winnipeg Acute Graft Versus Host Disease in Quebec City Acute Graft Versus Host Disease in Hamilton Acute Graft Versus Host Disease in Kitchener Acute Graft Versus Host Disease in London Acute Graft Versus Host Disease in Halifax Acute Graft Versus Host Disease in New York Acute Graft Versus Host Disease in Los Angeles Acute Graft Versus Host Disease in Chicago Acute Graft Versus Host Disease in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease